https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/researchers-identify-molecular-drivers-most-common-type-childhood-brain-tumour/
Researchers identify molecular drivers of most common type of childhood brain tumour
22 Mar 2016, 6:32 p.m.
A team of researchers has identified the molecular drivers behind the most common type of paediatric brain tumour.The research, from teams working at Great Ormond Street Hospital, the UCL Institute of Child Health and four other research institutions could improve the treatment of children with a type of brain tumour known as pilocytic astrocytoma.
The researchers carried out tests on brain tumour samples taken from 57 children, detailing microRNA (mRNA) and gene expression profiles alongside a pathway analysis. The findings suggested that there is a distinctive mRNA and gene expression profile in pilocytic astrocytoma when compared to other paediatric brain tumours.
Researchers found mRNA to be up-regulated and it is suggested that the resulting effect on the ERK/MAPK pathway contributes to the unique phenotype of pilocytic astrocytoma.
Pilocytic astrocytomas are the most common type of central nervous tumours in children. They are often slow growing, cystic well-circumscribed tumours that are most commonly situated within the cerebellum, making the removal of the tumour possible. However, many children are left with significant chronic disabilities following treatment.
The Great Ormond Street BRC supported the study, which is published in Acta Neuropathologica Communications.
Mystery of treatment resistant childhood leukaemia uncovered
Discovery of a new cancer cell type could enable testing to predict treatment-resistant blood cancer in children with a certain type of leukaemia.
New Director Designate announced for NIHR GOSH Biomedical Research Centre
Professor Paul Gissen has been announced as the Director Designate of the NIHR GOSH Biomedical Research Centre.
Study linking data from 85% of children in England compares rare cardiac risks post-COVID vs vaccination
A major study which analysed anonymised health records from over 14 million children in England has shown that rare heart and inflammatory issues were more likely - and lasted longer - after COVID-19 infection than after vaccination.
Celebrating research that transforms lives
The 2025 NIHR GOSH BRC Showcase recently celebrated some incredible progress made in paediatric research.